NEW: We have just launched DHbriefs to offer a series of research briefs covering specific digital health market niches. Click here for more information.

Nipro Diagnostics' TRUE METRIX AIR clears the FDA

Nipro Diagnostics' TRUE METRIX AIR clears the FDA

The U.S. Food and Drug Administration (FDA) has cleared Nipro Diagnostics' TRUE METRIX AIR Self-Monitoring blood glucose system, which allows diabetics to test blood glucose and deliver data wirelessly to a smartphone.

"Our new TRUE METRIX AIR Self-Monitoring blood glucose system is technology with reach," said Scott Verner, CEO and President of Nipro Diagnostics. "Nipro Diagnostics' customers have a better way to deliver superior health and wellness products that empower people with diabetes and their health support network to make better decisions for a healthier life," continued Verner.

Nipro is the diabetes store-brand leader and largest U.S. manufacturer of diabetes products for the store brand market. With TRUE METRIX AIR, the company is looking to elevate store brand product offerings that solve patient needs. The TRUE METRIX test strips feature TRIPLE SENSE TECHNOLOGY that detects, analyzes and corrects for environmental and physiological variability — including hematocrit and temperature — with proven precision and accuracy.

TRUE METRIX AIR will be available starting the second quarter of 2015 at a value price point through retail, mail and distribution channels under store brands and Nipro Diagnostics' own TRUE brand of products.

Leave a Reply

NEW: DHbriefs offers series of research briefs covering specific digital health market niches. Click here for more information.
Top